10x Genomics
362 hedge funds and large institutions have $11.9B invested in 10x Genomics in 2021 Q4 according to their latest regulatory filings, with 86 funds opening new positions, 121 increasing their positions, 107 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
362
Holders Change
+34
Holders Change %
+10.37%
% of All Funds
5.59%
Holding in Top 10
9
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+12.5%
% of All Funds
0.14%
New
86
Increased
121
Reduced
107
Closed
46
Calls
$29.7M
Puts
$37M
Net Calls
-$7.25M
Net Calls Change
+$36.1M
Top Buyers
| 1 |
Sands Capital Management
Arlington,
Virginia
|
+$248M |
| 2 |
DCP
D1 Capital Partners
New York
|
+$239M |
| 3 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$199M |
| 4 |
ClearBridge Investments
New York
|
+$111M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$77.6M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$181M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$175M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$89.1M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$75.3M |
| 5 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$65.7M |
